Outsourcing

Apr 01, 2018
BioPharm International
Early adopters are benefiting from lower costs and increased productivity.
Apr 01, 2018
BioPharm International
Access to multiple analytical techniques is essential for fully characterizing complex protein formulations.
Mar 30, 2018
By BioPharm International Editors
The contract research organization has added a new analytical laboratory in Middleton, WI, to expand its biologics testing capacity.
Mar 26, 2018
By BioPharm International Editors
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
Mar 26, 2018
By BioPharm International Editors
The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.
Mar 22, 2018
By BioPharm International Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 20, 2018
By BioPharm International Editors
An expanded pharma services supply chain facility in Germany boosts Thermo Fisher’s Pharma Services footprint in Europe.
Mar 16, 2018
By BioPharm International Editors
The new 73,000-square-foot facility is one of several expansions to support the company’s biologics testing capabilities.
Mar 16, 2018
By BioPharm International Editors
The contract development and manufacturing organization has expanded biologics capacity at its facility in Berkeley, CA.
Mar 15, 2018
BioPharm International
Research suggests that working with a single contract partner can reduce development time and improve economics.
native1_300x100
lorem ipsum